SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 121 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $11,220,000 | +63.6% | 101,500 | -68.8% | 0.19% | +276.5% |
| Q3 2014 | $6,858,000 | -66.1% | 325,000 | -52.2% | 0.05% | -66.7% |
| Q2 2014 | $20,257,000 | +3270.5% | 680,000 | +2620.0% | 0.15% | +2450.0% |
| Q1 2014 | $601,000 | -87.3% | 25,000 | -89.3% | 0.01% | -85.0% |
| Q4 2013 | $4,746,000 | -84.9% | 233,000 | -65.0% | 0.04% | -88.4% |
| Q3 2013 | $31,421,000 | +94.0% | 665,274 | +56.3% | 0.34% | +95.5% |
| Q2 2013 | $16,197,000 | – | 425,689 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |